JPRN-jRCT2080221242已完成2 期
A Phase 2 Randomized Study of LY2541546 versus Placebo in Postmenopausal Women with Low Bone Mineral Density:An Evaluation of the Dose Response Relationship Using Bone Mineral Density
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- •Have low BMD, defined as a T-score for lumbar spine of between -3.5 and -2.0, inclusive, based on the local DXA report as interpreted by the investigator. The method of determining Tscore values will be based on regional standards. Three of 4 vertebrae, L1 through L4, must be evaluable for BMD scoring, as measure by DXA.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A study of LY2541546 in Women with Low Bone Mineral DensityOsteoporosisEUCTR2010-019758-42-DKEli Lilly and Company132
进行中（未招募）
不适用
A study of LY2541546 in Women with Low Bone Mineral DensityMedDRA version: 13.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2010-019758-42-EEEli Lilly and Company132
进行中（未招募）
不适用
A study of LY2541546 in Women with Low Bone Mineral DensityMedDRA version: 14.0Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2010-019758-42-LTEli Lilly and Company153
进行中（未招募）
不适用
A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination with Atorvastatin, Simvastatin, and Rosuvastatin in Patients with Hypercholesterolemia or Low HDL-CEUCTR2009-017479-29-DKEli Lilly and Company400
进行中（未招募）
不适用
A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination with Atorvastatin, Simvastatin, and Rosuvastatin in Patients with Hypercholesterolemia or Low HDL-CHypercholesterolemia or Low HDL-CMedDRA version: 12.1Level: LLTClassification code 10020604Term: HypercholesterolemiaMedDRA version: 12.1Level: LLTClassification code 10024915Term: Low HDEUCTR2009-017479-29-NLEli Lilly and Company400